These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1014 related items for PubMed ID: 28369033

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. CRISPR/Cas9-Based Gene Dropout Screens.
    Wu K, Malek SN.
    Methods Mol Biol; 2019; 1881():185-200. PubMed ID: 30350207
    [Abstract] [Full Text] [Related]

  • 27. Applying CRISPR-Cas9 tools to identify and characterize transcriptional enhancers.
    Lopes R, Korkmaz G, Agami R.
    Nat Rev Mol Cell Biol; 2016 Sep; 17(9):597-604. PubMed ID: 27381243
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Analyzing CRISPR genome-editing experiments with CRISPResso.
    Pinello L, Canver MC, Hoban MD, Orkin SH, Kohn DB, Bauer DE, Yuan GC.
    Nat Biotechnol; 2016 Jul 12; 34(7):695-7. PubMed ID: 27404874
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A CRISPR-dCas Toolbox for Genetic Engineering and Synthetic Biology.
    Xu X, Qi LS.
    J Mol Biol; 2019 Jan 04; 431(1):34-47. PubMed ID: 29958882
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. More specific CRISPR editing.
    de Souza N.
    Nat Methods; 2014 Jul 04; 11(7):712. PubMed ID: 25110782
    [No Abstract] [Full Text] [Related]

  • 36. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA, Mashreghi MF.
    Z Rheumatol; 2017 Feb 04; 76(1):46-49. PubMed ID: 28124743
    [Abstract] [Full Text] [Related]

  • 37. CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
    Hryhorowicz M, Lipiński D, Zeyland J, Słomski R.
    Arch Immunol Ther Exp (Warsz); 2017 Jun 04; 65(3):233-240. PubMed ID: 27699445
    [Abstract] [Full Text] [Related]

  • 38. CRISPR technologies for bacterial systems: Current achievements and future directions.
    Choi KR, Lee SY.
    Biotechnol Adv; 2016 Nov 15; 34(7):1180-1209. PubMed ID: 27566508
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Genome-wide target specificities of CRISPR RNA-guided programmable deaminases.
    Kim D, Lim K, Kim ST, Yoon SH, Kim K, Ryu SM, Kim JS.
    Nat Biotechnol; 2017 May 15; 35(5):475-480. PubMed ID: 28398345
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.